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SPECIFIC AIMS
IL-6 has recently been demonstrated to be an impor-
tant inducer of the G-protein coupled C5a receptor
(C5aR) in various organs and tissues in rodents during
the early onset of cecal/ligation and puncture (CLP)-
induced sepsis. In the current report we sought to
investigate the effects of C5a on LPS-induced IL-6
generation in neutrophils in vitro and on in vivo IL-6
production in septic rodents and to describe underly-
ing intracellular signaling mechanisms.
PRINCIPAL FINDINGS
1. Effects of C5a on LPS-induced IL-6 production
and gene transcription
We investigated the effects of C5a on LPS-induced IL-6
production in blood neutrophils from healthy rats.
ELISA experiments with cell supernatants revealed that
10 nM C5a significantly enhanced LPS (20 ng/mL)-
induced IL-6 production in neutrophils at 2 and 4 h of
in vitro stimulation in an additive manner. This effect
of C5a was reflected at the transcriptional level.
2. Effects of blockade of C5a/C5aR activation on
serum IL-6 levels during sepsis
We sought to investigate the contribution of C5a/C5aR
activation on IL-6 serum levels during CLP-induced
sepsis in rodents. IL-6 serum levels in CLP rats peaked
6 h after CLP (Fig. 1A). To investigate the contribution
of neutrophils to IL-6 serum levels, experiments were
conducted in neutrophil-depleted animals, in which
serum IL-6 levels 6 h after CLP were greatly reduced
compared with neutrophil-intact group, suggesting
neutrophils as an important source of IL-6 during the
onset of sepsis (Fig. 1B). We further investigated the
effects of C5a on IL-6 serum levels in animals using
either control IgG or blocking antibody to C5a (anti-
C5a) given intravenously at the start of CLP. The
anti-C5a treated group showed significantly lower se-
rum IL-6 levels at 6 h CLP compared with control IgG
treated animals (Fig. 1C). CLP experiments in C5aR
deficient mice (C5aR/) showed sharply reduced
IL-6 serum levels at 6 h CLP compared with littermate
controls (Fig. 1D).
3. NF-B dependency of IL-6 production in
neutrophils
To address the question of whether IL-6 production in
neutrophils was NF-B dependent, we conducted ex-
periments in which neutrophils were preincubated with
an NF-B inhibitor (which blocks IB phosphoryla-
tion) before stimulation with LPS and C5a. IL-6 pro-
duction in rat neutrophils was completely suppressed
with the NF-B inhibitor (data not shown). In neutro-
phils from mice deficient in the NF-B subunit p50,
similar levels of IL-6 were produced after LPS stimula-
tion compared with littermate controls, suggesting that
IL-6 production in neutrophils was not dependent on
the NF-B subunit p50 even though dependent on
NF-B activation in general.
4. Effects of C5a and LPS on activation of MAPK
pathways in neutrophils
To investigate the underlying mechanisms for the ob-
served effects of C5a in LPS-induced IL-6 production in
neutrophils, we conducted Western blot experiments
with whole cell lysates from neutrophils that had been
stimulated in vitro with LPS, C5a or the combination of
LPS and C5a for various periods of time. C5a caused
rapid (within 5 min) phosphorylation of p38 mitogen-
activated protein kinase (p38 MAPK), p44/p42 MAPK
(ERK1/2), and p46 c-Jun N-terminal kinases ( JNK1/2)
(Fig. 2). In the case of ERK1/2 and JNK, phosphoryla-
tion was transient and observed after 5 min of in vitro
stimulation but not at 15 min, while p38 MAPK phos-
phorylation was still detected 30 min after in vitro
stimulation. LPS-induced phosphorylation of p38 could
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Figure 1. Effects of blockade of C5a/C5aR activa-
tion on serum IL-6 levels during sepsis. A) ELISA
analysis of rat serum samples at various time points
after CLP. Data are representative of 4–6 different
serum samples per group. B) ELISA analysis of
plasma samples for IL-6 from neutrophil-depleted
rats 6 h after CLP. Neutrophil-depletion was
achieved by intraperitoneal injection of anti-neu-
trophil antibody 18 h prior to CLP. Data are
representative of 4–5 animals per group. C) IL-6
ELISA analysis of rat serum samples at 6 h after
CLP in animals treated intravenously with anti-C5a
IgG (500g/rat) or equal amounts of irrelevant
IgG at the start of CLP. Data are representative of
6 different serum samples per group. D) IL-6
ELISA analysis of serum samples from C5aR/
and C5aR/ mice 6 h after CLP. Data are repre-
sentative of 4 different animals per group.
Figure 2. IL-6 ELISA analysis of rat neutrophil
supernatant fluids after 4 h stimulation at 37°C
with C5a (10 nM), LPS (20ng/mL), or both, and
accompanying Western blots from matching whole
cell lysates from neutrophils stimulated similarly
for 5 min. A) Effects of preincubation for 30 min
with 20 M MEK1/2 inhibitor (U0126). B) Effects
of preincubation for 30 min with 5 M JNK1
inhibitor (L-form peptide). C) Effects of preincu-
bation for 30 min with 20 M JNK2 inhibitor
(SP600125). D) Effects of preincubation for 30
min with 20 M p38 MAPK inhibitor (SB203580).
Data are representative of 2–3 independent exper-
iments with neutrophils pooled from 4–6 rats and
analyzed in triplicate. *Statistical significant differ-
ence from the LPS-only treated group.
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be observed at 15–30 min of incubation, peaking at 1 h,
but LPS alone did not cause phosphorylation of
ERK1/2 or JNK. In the C5aLPS costimulated neutro-
phils, an additive effect of p38 phosphorylation was
observed at incubation for 1 h (data not shown). These
data suggest that C5a is involved in rapid activation of
all three kinase pathways, and, in the case of p38,
appears to cause sustained (up to at least 1 h) phos-
phorylation when cells were costimulated with LPS
and C5a.
5. Effects of signaling pathway inhibitors on IL-6
production in neutrophils
The experiments in Fig. 2 indicated that C5a can
activate all three MAPK pathways, while LPS alone, with
time, only activated p38 MAPK in rat neutrophils.
Therefore, we investigated the ability of various signal-
ing pathway inhibitors to inhibit the enhancing effects
of C5a on LPS-induced IL-6 generation in neutrophils.
Neutrophils from normal rats were stimulated in vitro
for 4 h with C5a, LPS, or both, after preincubation at
37°C with various inhibitors for 30 min. Inhibition of
either MEK1/2 (which is upstream of ERK1/2) or
inhibition of p38 resulted in greatly suppressed IL-6
production in neutrophils (Fig. 2A,D). In these exper-
iments, C5a-induced phosphorylation of ERK1/2 and
p38 was almost completely abolished by inhibitors of
MEK1/2 or p38, as demonstrated in the accompanying
Western blots. High concentrations of the JNK1 inhib-
itor or JNK2 inhibitor resulted in no inhibition of IL-6
production, although C5a-induced phosphorylation of
JNK was inhibited by both of these compounds (Fig.
2B,C). These results suggest that the enhancing effects
of C5a on LPS-induced IL-6 production in neutrophils
may be elicited by enhanced phosphorylation of
ERK1/2 and p38 MAPK, but not JNK.
6. Effects of p38 and ERK1/2 inhibition on LPS-
induced IL-6 production and accompanying C5a
effects in neutrophils
The experiments depicted in Fig. 2 indicated that
LPS-induced production of IL-6 was dependent on p38
and ERK1/2 activation. We conducted similar experi-
ments in which neutrophils were preincubated with
different concentrations of each inhibitor followed by
stimulation with C5a, LPS or both (as described above).
Inhibition of either MEK1/2 or p38 activation dose-
dependently resulted in progressive inhibition of LPS-
induced IL-6 production in neutrophils. Preincubation
of neutrophils with the combination of MEK1/2 and
p38 inhibitors resulted in additive inhibition of IL-6
generation in neutrophils. Under such conditions, C5a
still elicited a significant additive effect on LPS-induced
IL-6 production (data not shown). These data suggest
that both pathways (p38 and ERK1/2) are involved in
LPS-induced IL-6 production in neutrophils in an
additive manner.
CONCLUSIONS
Little has been known about mechanisms responsible
for the early generation of proinflammatory mediators
such as IL-6 during the onset of sepsis. Our data suggest
that C5a has an additive effect on LPS-induced gener-
ation of IL-6 in neutrophils in vitro and that blockade
or genetic loss of C5aR in mice or antibody-blockade of
C5a significantly reduced serum levels of IL-6 during
sepsis. The availability of neutrophils appears to be
important for IL-6 generation during the onset of
sepsis. LPS-induced production of IL-6 in neutrophils
was NF-B-dependent (which has also been suggested
in other cell types) and dependent on phosphorylation
of p38 MAPK as well as p44/p42 MAPK (ERK1/2) but
not on phosphorylation of JNK1/2. C5a stimulation of
neutrophils elicited a rapid phosphorylation of ERK1/2
and p38 MAPK. Accordingly, we suggest that induction
of IL-6 after CLP is neutrophil and C5a/C5aR-depen-
dent, likely due to the ability of C5a to cause activation
of ERK1/2 and p38 MAPK signaling pathways with a
common distal activation of mitogen and stress acti-
vated kinase 1/2 (MSK 1/2) (Fig. 3). In the context of
earlier findings from our group, the current data
suggest positive feedback mechanisms in which early
generation of C5a during the onset of sepsis leads to
enhanced IL-6 production, resulting in enhanced C5aR
expression in various organs and possibly in increased
susceptibility to C5a-induced harmful effects on organ
function. Understanding the underlying intracellular
mechanisms for this regulatory role of C5a may help to
develop new therapeutic targets for the treatment of
sepsis.
Figure 3. Schematic diagram depicting the employed signal-
ing pathways in neutrophils for IL-6 production during the
onset of sepsis in the presence of C5a and LPS.
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